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The fungal component of the human gut microbiota has been neglected for long time
due to the low relative abundance of fungi with respect to bacteria, and only recently few
reports have explored its composition and dynamics in health or disease. The application
of metagenomics methods to the full understanding of fungal communities is currently
limited by the under representation of fungal DNA with respect to the bacterial one,
as well as by the limited ability to discriminate passengers from colonizers. Here, we
investigated the gut mycobiota of a cohort of healthy subjects in order to reduce the
gap of knowledge concerning fungal intestinal communities in the healthy status further
screening for phenotypical traits that could reflect fungi adaptation to the host. We
studied the fecal fungal populations of 111 healthy subjects by means of cultivation
on fungal selective media and by amplicon-based ITS1 metagenomics analysis on a
subset of 57 individuals. We then characterized the isolated fungi for their tolerance to
gastrointestinal (GI) tract-like challenges and their susceptibility to antifungals. A total
of 34 different fungal species were isolated showing several phenotypic characteristics
associated with intestinal environment such as tolerance to body temperature (37◦C),
to acidic and oxidative stress, and to bile salts exposure. We found a high frequency of
azoles resistance in fungal isolates, with potential and significant clinical impact. Analyses
of fungal communities revealed that the human gut mycobiota differs in function of
individuals’ life stage in a gender-related fashion. The combination of metagenomics and
fungal cultivation allowed an in-depth understanding of the fungal intestinal community
structure associated to the healthy status and the commensalism-related traits of isolated
fungi. We further discussed comparatively the results of sequencing and cultivation
to critically evaluate the application of metagenomics-based approaches to fungal gut
populations.
Keywords: commensal fungi, human gut mycobiota, antifungal resistance, fungal metagenomics, fungi-host
interactions
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INTRODUCTION
The human gut is a complex ecological niche in which
archaea, bacteria, protozoa, fungi, and viruses co-exist in close
association with the host (Reyes et al., 2010; Arumugam et al.,
2011; Human Microbiome Project Consortium, 2012). Even
if it has been estimated that the number of bacteria hugely
outreaches the number of fungi in the gastrointestinal (GI)
tract (Huffnagle and Noverr, 2013), fungi play a relevant
role in the physiology of the human host (Oever and Netea,
2014; Underhill and Iliev, 2014). Recent studies showed that,
while the composition of the bacterial community is relatively
stable over time, the fungal population inhabiting the murine
gut undergoes significant changes during the animal’s lifetime
(Dollive et al., 2013). This brought to the conclusion that gut
fungal populations are more variable than bacterial ones and
that their compositionmay be influenced by environmental fungi
(Underhill and Iliev, 2014). Despite evidence that fungi inhabit
the mammalian GI tract and interact with the host immune
system (Romani, 2011; Rizzetto et al., 2014; Underhill and Iliev,
2014), the composition and characteristics of the mycobiota
in healthy hosts have been poorly explored. The prevalent
interest in describing pathogenic fungi, their phenotypes and
the process by which they establish the infection is one of
the major cause that brought to neglect the harmless part
of the commensal fungal population. Despite this topic has
been only marginally explored to date, it has been shown that
mucosal fungi are able to modulate both the innate and adaptive
immune responses (Romani, 2011; Rizzetto et al., 2014; Underhill
and Iliev, 2014) thus supporting the need to further study
the whole gut mycobiota. Furthermore, alterations of the gut
mycobiota have been associated to different pathologies ranging
from metabolic disorders (obesity) to colorectal adenomas and
Inflammatory Bowel Diseases (IBDs) (Luan et al., 2015; Mar
Rodriguez et al., 2015; Sokol et al., 2016). A recent study showed
the association of IBDs to alteration of the gut mycobiota.
In particular Sokol and colleagues showed that IBD patients
bear a smaller proportion of Saccharomyces cerevisiae and
higher of Candida albicans compared to healthy subjects. In
addition, they highlighted the existence in Crohn’s disease
of interconnected alterations between bacterial and fungal
communities (Sokol et al., 2016). However, the role of the gut
mycobiota in the maintenance of health it is still far from
being well-understood because the studies carried out so far
focused on disease-causing taxa. Nevertheless, some yeasts have
been clinically prescribed for a long time because of their
potential probiotic properties, suggesting a beneficial role of
some fungi for host health. A great example of “beneficial”
fungus is represented by S. cerevisiae var. boulardii, used for
the relief of gastroenteritis (Hatoum et al., 2012). In order to
reduce the gap of knowledge concerning the gut mycobiota
and its interplay with the host, we characterized the gut
mycobiota composition of a cohort of healthy subjects by




Fecal samples were collected from 111 Italian healthy volunteers
(49 male and 62 female, average age, 10 ± 8.2; Table 1)
and analyzed within 24 h. Written informed consent has
been obtained from all the enrolled subjects or tutors in
accordance with the guidelines and regulations approved by
the Research Ethical Committees of the Meyer Children’s
Hospital and the Azienda Ospedaliera Careggi, Florence.
All the subjects enrolled were non-smokers, followed a
Mediterranean-based diet and they did not take antibiotics,
antifungals or probiotics in the 6 months prior to sample
collection. None of the participants had any history of GI
abnormalities.
Isolation and Identification of Cultivable
Fungal Species from Feces
Stool samples were diluted in sterile Ringer’s solution and
plated on solid YPD medium (1% Yeast extract, 2% Bacto-
peptone, 2% D-glucose, 2% agar) supplemented with 25 U/ml
of penicillin, 25µg/ml of streptomycin (Sigma-Aldrich) and
incubated aerobically at 27◦C for 3–5 days. All fungal isolates
grown on the selective medium were further isolated to obtain
single-cell pure colonies. Genomic DNA was extracted from pure
cultures of isolated colonies as previously described (Hoffman
and Winston, 1987). Strains were identified by amplification
and sequencing of the ribosomal Internal Transcribed Spacer
(ITS) region, using ITS1 (5′-GTTTCCGTAGGTGAACTTGC-
3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) primers, as
previously described (Sebastiani et al., 2002). Fungal isolates were
identified by using the BLAST algorithm in the NCBI database
(minimum 97% sequence similarity and 95% coverage with a
described species).
Phenotypical Characterization of Fungal
Isolates
Fungal isolates were tested for phenotypical features that could
be related to the ability of colonization and persistence in the
human gut. Cell growth in liquid media was monitored by
optical density measurement at 630 nm with a microplate reader
(Synergy2, BioTek, USA) after 48 h of incubation under tested
conditions. Three independent replicates were performed for
each test.
Growth at Supra Optimal Temperatures
Fungal isolates (∼105 cells/ml) were grown at supra optimal
temperatures in liquid YPD medium (40, 42, 44, and 46◦C).
pH Impact on Growth
Fungal isolates (∼105 cells/ml) were grown at 37◦C in liquid
YPD medium at pH 2.0 and pH 3.0 adding hydrochloric
acid/potassium chloride and citrate buffers, respectively, to test
their ability to resist to the acidic environments encountered
during GI tract passage.
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TABLE 1 | Characteristics of the study participants.
Age group (year) Infants (0–2) Children (3–10) Adolescents (11–17) Adults (≥18) All subjects
Number of subjects 18 48 24 21 111
% with fungi 88.9 83.3 70.8 76.2 80.2
Subject ID Gender Age (year) Subject ID Gender Age (year) Subject ID Gender Age (year)
HS1 M 5 HS38* F 25 HS75 F 1
HS2 M 5 HS39* F 27 HS76* M 1
HS3 M 14 HS40* M 27 HS77 F 4
HS4 M 1 HS41* F 24 HS78* M 12
HS5 F 20 HS42* F 24 HS79* M 0.1
HS6 F 20 HS43* M 26 HS80 F 0.1
HS7 F 20 HS44* F 24 HS81 F 7
HS8 M 5 HS45* F 6 HS82* M 10
HS9 M 14 HS46* F 6 HS83* M 12
HS10* F 2 HS47* F 10 HS84 F 6
HS11 M 16 HS48* F 2.5 HS85 F 10
HS12 M 15 HS49* M 2.5 HS86* M 7
HS13* F 18 HS50* F 1.5 HS87* M 9
HS14 F 0.3 HS51* F 8 HS88* M 7
HS15* F 11 HS52* F 23 HS89* M 12
HS16 M 14 HS53* F 23 HS90 F 8
HS17 M 15 HS54 M 2 HS91 F 2
HS18 M 11 HS55* M 2 HS92 F 12
HS19 F 3 HS56* M 2 HS93 F 4
HS20* F 4 HS57 F 12 HS94 F 4
HS21* F 5 HS58 F 3 HS95 F 10
HS22* F 15 HS59* M 5 HS96 F 12
HS23* F 11 HS60 F 3 HS97* M 6
HS24 M 15 HS61* M 2 HS98 F 16
HS25 M 7 HS62 F 4 HS99 F 3
HS26 M 3 HS63* M 5 HS100* M 0.1
HS27* F 9 HS64 F 3 HS101* M 4
HS28 M 5 HS65* M 5 HS102 F 13
HS29* F 16 HS66* M 0.1 HS103* M 7
HS30* F 12 HS67 F 1 HS104* M 4
HS31* F 24 HS68 F 4 HS105 F 8
HS32* F 32 HS69* M 6 HS106 F 5
HS33* F 32 HS70 F 11 HS107 M 13
HS34* F 25 HS71* M 1 HS108 M 4.5
HS35* F 26 HS72 F 10 HS109 M 1
HS36* M 20 HS73 F 4 HS110 M 12
HS37* F 28 HS74* M 6 HS111 M 18
*Samples analyzed also by mean of amplicon-based ITS1metagenomics.
Tolerance to Bile Acids
Fungal isolates (∼105 cells/ml) were grown in liquid YPD
medium at 37◦C in the presence of three different concentrations
of bile [Ox-bile, Sigma-Aldrich; 0.5, 1, and 2% (w/v)]
mimicking the physiological intestinal settings (Noriega
et al., 2004).
Resistance to Oxidative Stress
Fungal resistance to oxidative stress was evaluated by measuring
the inhibition halo induced by the treatment of fungal strains
(∼107 cells/ml) grown on YPD solid medium with 0.5mM
hydrogen peroxide (H2O2). The percentage of sensitivity to
oxidative stress was calculated as the deviation of the inhibition
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halo diameter (Ø) from that of the environmental, oxidative
stress sensitive M28-4D S. cerevisiae strain (Cavalieri et al., 2000)
according to the following formula: [(Ø sample—Ø M28-4D)/Ø
M284D]*100.
Invasive Growth
The ability of fungal strains to penetrate the YPD solid medium
was tested as previously described (Vopalenska et al., 2005).M28-
4D and BY4742 S. cerevisiae strains, known to be invasive and
non-invasive, respectively, have been used as controls. The strain
invasiveness was assigned with scores from 3 (highly invasive) to
0 (non-invasive).
Hyphal Formation
Fungal cells (∼105 cells/ml) were grown for 7 days in liquid YPD
and YNBmedia [0.67% Yeast Nitrogen Base w/o aminoacids and
(NH4)2SO4 (Sigma-Aldrich), 2% glucose], both at 27 and 37◦C in
order to evaluate hyphae or pseudohyphae formation. Formation
of hyphae was inspected by optical microscope observation with
a Leica DM1000 led instrument (magnification 40x and 100x).
Antifungal Susceptibility Testing
All fungal isolates were tested for susceptibility to fluconazole,
itraconazole, and 5-flucytosine (Sigma-Aldrich) by Minimum
Inibitory Concentration (MIC) assays according to the European
Committee on Antimicrobial Susceptibility Testing (EUCAST)
recommendations (Rodriguez-Tudela et al., 2008a,b). Clinical
and Laboratory Standards Institute (CLSI) clinical breakpoints
(CBPs) were used to evaluate the antifungal resistance (Pfaller
and Diekema, 2012; Castanheira et al., 2014). CBPs have not
been established for non-Candida yeasts and non-Aspergillus
molds, however have been used as a proxy for the evaluation of
antifungals susceptibility in such isolates.
DNA Extraction and PCR Amplification of
Fungal ITS1 rDNA Region
DNA extraction from fecal samples (250 mg) was performed
using the FastDNATM SPIN Kit for Feces (MP-Biomedicals,
USA) following manufacturer’s instructions. DNA quality
was checked on 1% agarose gel TAE 1X and quantified
with a NanoDrop R© spectrophotometer. For each sample,
fungal ITS1 rDNA region was amplified using a specific
fusion primer set coupled with forward primer 18SF (5′-
GTAAAAGTCGTAACAAGGTTTC-3′) and reverse primer
5.8S1R (5′-GTTCAAAGAYTCGATGATTCAC-3′; Findley et al.,
2013) containing adaptors, key sequence and barcode (Multiple
IDentifier) sequences as described by the 454 Sequencing
System Guidelines for Amplicon Experimental Design (Roche,
Switzerland). The PCR reaction mix contained 1X FastStart High
Fidelity PCR buffer, 2mM MgCl2, 200µM of dNTPs, 0.4µM
of each primer (PRIMM, Italy), 2.5 U of FastStart High Fidelity
Polymerase Blend, and 100 ng of gDNA as template. Thermal
cycling conditions used were 5min at 95◦C, 35 cycles of 45 s
at 95◦C, 45 s at 56◦C, and 1.30min at 72◦C followed by a final
extension of 10min at 72◦C. All PCR experiments were carried
out in triplicates using a Veriti R© Thermal Cycler (Applied
Biosystems, USA).
Library Construction and Pyrosequencing
The PCR products obtained were analyzed by gel electrophoresis
and cleaned using the AMPure XP beads kit (Beckman Coulter,
USA) following the manufacturer’s instructions, quantified via
quantitative PCR using the Library quantification kit—Roche 454
titanium (KAPA Biosystems, USA) and pooled in equimolar way
in a final amplicon library. The 454 pyrosequencing was carried
out on the GS FLX+ system using the XL+ chemistry following
the manufacturer’s recommendations (Roche, Switzerland).
Data Analysis
Pyrosequencing resulted in a total of 1.337.184 reads with a
mean of 19.379 ± 13.334 sequences per sample. Raw 454
files were demultiplexed using the Roche’s sff file software
and submitted to the European Nucleotide Archive with
accession number PRJEB11827 (http://www.ebi.ac.uk/ena/data/
view/PRJEB11827). Sample accessions andmetadata are available
in Supplementary Table S1. Reads were pre-processed using the
MICCA pipeline (Albanese et al., 2015) (http://www.micca.org).
Forward and reverse primers trimming and quality filtering were
performed using micca-preproc. De-novo sequence clustering,
chimera filtering, and taxonomy assignment were performed
by micca-otu-denovo: Operational Taxonomic Units (OTUs)
were assigned by clustering the sequences with a threshold of
97% pairwise identity and their representative sequences were
classified using the RDP classifier version 2.8 (Wang et al., 2007)
against the UNITE fungal ITS database (Koljalg et al., 2013). De
novomultiple sequence alignment was performed using T-Coffee
(Notredame et al., 2000). Fungal taxonomy assignments were
then manually curated using BLASTn against the GenBank’s
database for accuracy. High quality fungal sequences were
detected in all samples. Furthermore, the sequences belonging to
Agaricomycetes [unlikely to be residents of the human gut due to
their ecology Hibbett, 2006] were manually filtered out.
The phylogenetic tree was inferred by using micca-phylogeny
(Price et al., 2010). Rarefaction analysis resulted in a sequencing
depth adequate to capture the ecological diversity of the
samples up to saturation. Sampling heterogeneity was reduced
by rarefaction.Alpha and beta-diversity estimates were computed
using the phyloseq R package (McMurdie and Holmes, 2013).
PERMANOVA (Permutational multivariate analysis of variance)
was performed using the adonis() function of the veganR package
with 999 permutations. Permutations have been constrained
within age groups (corresponding to 0–2, 3–10, 11–17, and >18
y/o) or gender to reduce possible biases related to the unequal
age and gender distributions among subjects using the “strata”
argument within the adonis() function. Two-sided, unpaired
Welch t-statistics were computed using the function mt() in the
phyloseq library and the p-values were adjusted for multiple
comparison controlling the family-wise Type I error rate (minP
procedure; Westfall and Young, 1993). Wilcoxon rank-sum tests
and Spearman’s correlations were performed using the R software
(Team, 2014) through the stats R package (version 3.1.2) and the
psych R package (Revelle, 2013), respectively. p-values have been
corrected for multiple comparison by using the false discovery
rate correction (Benjamini and Hochberg, 1995).
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RESULTS
Cultivable Gut Mycobiota
The cultivable gut mycobiota of 111 healthy volunteers was
investigated through isolation in selective media. Fungi
were detected in more than 80% of subjects leading to the
identification of 349 different isolates (Supplementary Table S2).
Thirty-four different fungal species were detected at different
frequencies of isolation (Table 2) among which Aspergillus
glaucus, Candida albicans, Candida deformans, Candida
fermentati, Candida glabrata, Candida intermedia, Candida
lusitaniae, Candida metapsilosis, Candida parapsilosis,
Candida pararugosa, Candida tropicalis, Candida zelanoydes,
Cryptococcus saitoi, Lichtheimia ramosa, Mucor circinelloides,
Pleurostomophora richardsiae, Rhodotorula mucilaginosa,
Trichosporon asahii, Yarrowia lipolytica. These species were
previously found in different human body sites, including the GI
tract as commensal or opportunistic pathogens (Araujo et al.,
2007; Johnson, 2009; Alastruey-Izquierdo et al., 2010; Kurtzman
et al., 2011; Levenstadt et al., 2012; Gouba et al., 2014; Lee et al.,
2014; Rizzetto et al., 2014). We also isolated the environmental
fungi Aspergillus pseudoglaucus, Eurotium amstelodami,
Eurotium rubrum, Penicillium brevicompactum, Penicillium
paneum, Penicillium crustosum, Pichia caribbica, Pichia
fermentans, Pichia kluyveri, Pichia manshurica, Rhodosporidium
kratochvilovae, Saccharomyces cerevisiae, Starmerella bacillaris,
and Torulaspora delbrueckii. Such species were previously found
in fermentations, oenological samples (Chitarra et al., 2004;
Butinar et al., 2005; Kurtzman et al., 2011; Barata et al., 2012;
Bezerra-Bussoli et al., 2013; Tristezza et al., 2013; Vardjan et al.,
2013; Belda et al., 2015; de Melo Pereira et al., 2014; Santini et al.,
2014; Wang et al., 2014) and rarely found in clinical samples (de
la Camara et al., 1996; Kaygusuz et al., 2003; Butinar et al., 2005;
Rizzetto et al., 2014). The 39.8% of subjects showed at least one
C. albicans isolate, which resulted in the most common yeast
species found in our samples, in line with previous reports on the
gut mycobiota of healthy subjects (Khatib et al., 2001; Bougnoux
et al., 2006).
Population level analysis of the cultivable gut mycobiota
revealed significant gender-related differences, with female
subjects showing a higher number of fungal isolates (p <
0.005, Wilcoxon rank-sum test; Figure 1A) and fungal species
(p < 0.05, Wilcoxon rank-sum test; Figure 1B) compared to
male subjects (not related to individual’s age) while we did not
observed significant differences in the fungal population among
the investigated age groups (Figures 1C,D). Finally, no species
per se was responsible for these differences, as indicated by
the fact that we did not find significant differences between
individual species abundances inmale and female subjects for any
investigated age group.
Fungal Gut Metagenomics
To better characterize the intestinal fungal community structure
associated to our cohort of healthy subjects we further analyzed
a subset of these subjects (57 subjects, 29 females, and 28
males, average age 12 ± 9.5) by means of amplicon-based
ITS1 targeted metagenomics, looking at gender and age groups
TABLE 2 | Fungal isolates and frequencies of isolation.
Species % Species %
Candida albicans 39.8 Rhodosporidium kratochvilovae 0.57
Rhodotorula mucilaginosa 12.6 Trichosporon asahii 0.57
Candida parapsilosis 12.3 Yarrowia lipolytica 0.57
Torulaspora delbrueckii 6.59 Aspergillus cristatus 0.28
Pichia fermentans 4.29 Candida deformans 0.28
Penicillium brevicompactum 3.72 Candida fermentati 0.28
Pichia manshurica 3.43 Candida glabrata 0.28
Pichia kluyveri 2.86 Candida intermedia 0.28
Candida lusitaniae 2.58 Candida metapsilosis 0.28
Pennicillium crustosum 1.43 Candida tropicalis 0.28
Saccharomyces cerevisiae 1.14 Candida zelanoydes 0.28
Penicillium paneum 0.58 Eurotium amstelodami 0.28
Aspergillus glaucus 0.57 Eurotium rubrum 0.28
Aspergillus pseudoglaucus 0.57 Lichtheimia ramose 0.28
Candida pararugosa 0.57 Pichia carribica 0.28
Cryptococcus saitoi 0.57 Pleurostomophora richardsiae 0.28
Mucor circinelloides 0.57 Starmerella bacillaris 0.28
differences. The analysis led to the identification of 68 fully
classified (to the genus level) fungal taxa and 26 taxa only
partially classified (of which 2 classified to the phylum level,
5 classified to the order level, 9 classified to the class level,
and 9 classified to the family level). Measurements of the
fungal richness within each sample i.e., the alpha-diversity
(see Materials and Methods), revealed no significant differences
among male and female subjects (Figure 2A), differently from
the above finding based on the culture-based analysis in which
we observed an increased number of intestinal fungal species
in females compared to males (Figure 1B). Furthermore, we
observed that infants and children harbor a higher fungal
richness compared to adults as indicated by the number of
the observed OTUs (p < 0.05, Wilcoxon rank-sum test,
Figure 2B). The analysis of beta-diversity identified significant
differences in the composition of the gut mycobiota among
gender and age groups. PCoA (Principal Coordinates Analysis)
revealed that samples cluster by gender, based on the unweighted
UniFrac distance and the Bray-Curtis dissimilarity (p < 0.05,
PERMANOVA; Figures 2C,D, Supplementary Table S3) and by
age groups, based on the unweighted UniFrac distance (p <
0.05, PERMANOVA; Figure 2C, Supplementary Table S3). We
calculated PERMANOVAs constraining permutations within
levels (gender or age groups) to avoid biases related to the
unequal distribution of genders among age groups and vice-
versa. Genus level analysis showed Penicillium, Aspergillus,
and Candida as the most abundant genera in this subset
of subjects (22.3, 22.2, and 16.9%, respectively; Figure 3,
Supplementary Table S4). We further observed that Aspergillus
and Tremellomycetes_unidentified_1 were significantly more
abundant in male than female subjects (p < 0.05, Welch t-
test) and in children than adults (p < 0.05, Welch t-test).
To note, the latter result could be biased by the unbalanced
distribution of male and female subjects in children and adults
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A C
B D
FIGURE 1 | Gender-related and age-related differences in the gut mycobiota of 111 healthy volunteers. Histogram of the mean of (A) abundances and (B)
the richness ± standard error of fungal isolates in female and male subjects; box-plot representation of the (C) abundance and (D) richness of fungal isolates in
different age groups i.e., infants (0–2 years old), children (3–10 years old), adolescents (11–17 years old) and adults (≥18 years old). **p < 0.005, *p < 0.05, Wilcoxon
rank-sum test.
groups (14/22 male children and 3/17 male adults). Furthermore,
the genus Penicillium was significantly more abundant in infants
than adults (p < 0.05, Welch t-test). Interestingly, we identified
sequences belonging to the single-cell protozoa Blastocystis,
eukaryotes abundant in the human gut microbiota (Scanlan
and Marchesi, 2008), only in adolescent and adult females
(Figure 3, Supplementary Table S4) that could potentially be
due to exposure to animals (Scanlan et al., 2014).
Phenotyping the Gut Mycobiota
The characterization of phenotypic features of the isolates related
to the ability to survive and colonize the human gut was
performed to estimate if such isolates were commensals adapted
to this ecological niche or passengers introduced through the diet
and delivered with the feces.
We therefore investigated the isolates’ resistance by a series of
assays mimicking the conditions that fungal isolates face during
passage through the human GI tract. In addition to the fact that
the human body temperature (37◦C) is higher than the optimum
for most fungal species, in the GI tract fungi are also exposed
to acidic and oxidative environments and to bile salts, produced
by the liver and secreted into the duodenum, exposing the
microorganisms to oxidative stress and DNA damage (Kandell
and Bernstein, 1991).
The majority of the isolates were found to tolerate acidic
conditions (58.9 and 94.8% of isolates were able to grow at pH
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A B
C D
FIGURE 2 | Box-plot representation of fungal alpha-diversity measures using the number of observed OTUs between (A) genders or (B) age groups
and measures of fungal beta-diversity by PCoA of the between samples distances measured using (C) the unweighted UniFrac distance and (D) the
Bray-Curtis dissimilarity. *p < 0.05, Wilcoxon rank-sum test.
2 and pH 3, respectively) and oxidative stress (85.7% of the
isolates showed higher tolerance compared to environmental
M28 S. cerevisiae strain), both conditions are characteristic of
the gut environment. Tolerance to physiological concentrations
of bile acids was also observed (89.8, 87.5, and 85.7% of fungal
isolates were able to grow in presence of ox-bile 0.5, 1, and
2%, respectively) as well as the ability to grow at supra optimal
temperatures with almost all the isolates (99.4%) being able
to grow at 37◦C (Supplementary Table S2). The comparison
of the growth ability of such isolates at pH 3 and at growing
concentrations of ox-bile (i.e., 0.5, 1.0, and 2.0% ox-bile) with
respect to the control growth condition (37◦C, no bile, pH 6.5)
revealed that these stressful conditions do not significantly affect
the growth ability of the fungal isolates (Figure 4). By contrast,
a significant growth reduction was observed when comparing
the isolated grown at pH 2 with respect to the control growth
condition (p < 0.0001, Wilcoxon rank-sum test; Figure 4). As
expected, a progressive reduction of growth ability was observed
in correspondence of incubation temperature increase (i.e., from
40 to 46◦C) for all the tested isolates (p < 0.0005, Wilcoxon
rank-sum test; Figure 4).
In addition to the ability of fungal isolates to tolerate the
intestinal environmental stresses, we also explored their ability to
undergo phenotypic changes favoring their persistence within the
human gut. Among these, we assessed the formation of hyphae
and the ability to penetrate the solid growth medium, thus to
adhere to host tissues. The 56.9% of fungal isolates was able
to form hyphae or pseudohyphae (Supplementary Table S2).
In addition, the morphotype switch to hyphae and pseudo-
hyphae was related to the isolates’ invasiveness, with hyphae
and pseudohyphae-forming isolates being the most invasive
(Figure 5A), suggesting that such isolates may be able to
Frontiers in Microbiology | www.frontiersin.org 7 August 2016 | Volume 7 | Article 1227
Strati et al. Healthy Gut Mycobiota
FIGURE 3 | Stacked bar-plot representation of the relative abundances at the genus level of the fecal mycobiota of healthy subjects from
metagenomics analysis distributed according to individuals’ life stage and gender.
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FIGURE 4 | Box-plot representation of the comparison of fungal isolates growth ability at 37◦C (control condition) vs. different stressful conditions
mimicking the gastrointestinal tract challenges. **p < 0.0005, ***p < 0.0001, Wilcoxon rank-sum test.
adhere to or invade the host tissues. Furthermore, we observed
that hyphae-forming isolates are significantly more resistant to
itraconazole than pseudohyphae-forming isolates and isolates
unable to form hyphae (p < 0.05, Wilcoxon rank-sum test;
Figure 5B). These phenotypic traits in conditions of altered
immune system or in association with intestinal dysbiosis, could
represent a pathogenic potential for the host.
It is now recognized that inappropriate antifungal use
contributes to the increase in microbial antifungal resistance,
complicating therapeutic intervention, and the eventual
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A B
FIGURE 5 | Box-plot representation of fungal isolates able (or not) to produce hyphae or pseudohyphae in relationship with (A) their ability to be
invasive on YPD solid medium, (B) their resistance to itraconazole. *p < 0.05, **p < 0.005, ***p < 0.001, Wilcoxon rank-sum test.
eradication of pathogens (Chen et al., 2010; Arendrup et al.,
2011). Due to the relevance of such aspect and its impact on
clinical studies, we tested all fungal isolates for their susceptibility
to the widely therapeutically used azoles, fluconazole, and
itraconazole (Martin, 2000) as well as the non-azole antifungal
5-flucytosine (Vermes et al., 2000). A total of 31.5% of the isolates
were resistant to fluconazole and, as expected, similar levels of
itraconazole resistance were found (for 39.2% of the isolates the
MIC was ≥1µg/ml; Supplementary Table S2). Previous studies
have indeed suggested that cross-resistance may occur between
fluconazole and other azole compounds (i.e., itraconazole)
(Pfaller et al., 2006) and we further confirmed such observations
with the finding of a significant positive correlation between
the isolates resistance to these two antifungals (Spearman’s
r = 0.43, p < 0.05; Figure 6). Most of the isolates (99.34%)
showed high susceptibility to 5-flucytosine with most MIC
values ≤0.125µg/ml (Supplementary Table S2). Among the
9 most abundant species (at least 6 isolates per species),
C. albicans, Pichia spp. and Rhodotorula mucillaginosa showed
the highest resistance to fluconazole, with MIC90 > 64µg/ml
(Table 3). Furthermore, it is worth to note that resistance to
tested antifungals is positively correlated with the ability of
strains to grow under stressful conditions, such as supra optimal
temperature, acidic conditions, and bile salts exposure (p < 0.05,
Spearman’s r correlation; Figure 6).
DISCUSSION
The vast majority of fungal species inhabiting our body are
commensals and opportunistic pathogens that could turn into
potential threats depending on strain virulence traits and on the
status of the host’s immune system. In this perspective to discover
a pathogenic infection it seems crucial to define exactly which
species are normally present in a given body district.
The humanGI tract is known to contain variable communities
of bacteria but also fungi have an important role in this
ecological niche (Underhill and Iliev, 2014). Nevertheless, the
phylogenetic characterization of fungal microorganisms and
their specific role as part of the GI niche have not yet been studied
extensively.
The advent of sanitation and food globalization has reduced
the possibility for humans to come across with the richness of
fungal species present in traditional fermented foods. Fungal
infections are an ever increasing problem either as side effects
of antibiotics use, high dose chemotherapy, and of the spread
of immunosuppressive diseases. Estimates of global mortality
rates suggest that fungi are responsible for more deaths than
either tuberculosis or malaria (Brown et al., 2012). Most of this
mortality is caused by species belonging to four fungal genera:
Aspergillus, Candida, Cryptococcus, and Pneumocystis that are
rapidly becoming resistant tomost antifungal drugs (Brown et al.,
2012; Denning and Bromley, 2015). The information on these
fungi so far derives from the study of lung infections, while little
is known on the gut mycobiota composition and its role in health
and disease. The knowledge on the gut mycobiota is currently
limited to few studies making it difficult to assess the significance
of differences found in the intestinal fungal populations of
diseases such as IBDs due to the lack of information on what the
healthy mycobiota is. Here we aimed at defining the “healthy”
gut mycobiota, showing that the intestinal fungal community of
a cohort of Italian healthy volunteers is a variegate ecosystem
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FIGURE 6 | Spearman’s r correlation analysis between antifungals susceptibility and growth ability of the tested fungal isolates under different stress
conditions. Solid squares represent the degree of correlation among the variables taken into account. Crossed squares indicate non-significant correlations;
significant results with p < 0.05.
that differs in function of individuals’ life stage in a gender-
dependent manner. We identified 34 fungal species of different
ecological origins. While the majority of our fungal isolates has
been previously described as inhabitants of the mammalian GI
tract (Kurtzman et al., 2011; Rizzetto et al., 2014), some of
the isolates belong to species so far identified in environmental
samples only. Environmental fungi, in particular putative food-
borne fungi, have been previously observed to be able to survive
the transition through the GI tract possibly being metabolically
active in the gut (David et al., 2014). The phenotypic properties
of fungi isolated in this study suggested that these isolates are able
to survive in the human GI tract, prompting the hypothesis of
an ecological selection and potential ability to colonize this niche
(David et al., 2014). Indeed the phenotypic features of the fungal
isolates identified endow such isolates with an excellent ecological
fitness in the human GI tract. We observed that approximately
half of the isolates form hyphae or pseudohyphae, which are
known to be involved in the adhesion to or penetration within
the GI mucosa (Staab et al., 2013), consolidation of the colony,
nutrient intake and formation of 3-dimensional matrices (Brand,
2011). A key factor of C. albicans commensalism/pathogenicity is
its ability to switch between different morphologies, comprising
cellular, pseudohyphae, and hyphae forms. As reported for
C. albicans, the reversible transition to filamentous growth as a
response to environmental cues (Sudbery, 2011) and phenotypic
switching is essential for mucosal fungal colonization (Vautier
et al., 2015).
Previous studies have also shown that C. albicans over-
expresses a wide range of genes involved in resistance to high
temperature and pH, oxidative stress, and hyphae formation
during ileum and colon commensal colonization of BALB/c mice
(Pierce et al., 2013). Similarly, the fungal isolates of this study,
showing resistance to oxidative, high temperature, bile acids, and
pH stresses may hold the potential to colonize the human gut. It
is plausible that fecal fungal isolates with specific characteristics
(such as high resistance to acidic pH and bile salts) survived to
the gut environment, and that these traits make them able to
colonize the gut. Thus, we can hypothesize a long process of
evolution, selection or adaptation of environmental and food-
borne strains to the human host, suggesting that pathogenic
strains of commensal species can evolve through a repeated
process of evolution and selection, depending on the immune
status of the host (De Filippo et al., 2014). These findings
encourage for in-depth, strain-level extensive studies on human
gut mycobiota and the integration of such data with immunology
to further establish the relevance of fungi in host physiology and
host-microbe interaction. Furthermore, fungi may train host’s
immune system simply when passengers, rather than necessarily
persisting only as continuous colonizers (Rizzetto et al., 2016).
We discovered that several fungal isolates displayed different
levels of antifungal resistance. About 20 years ago, azole-
sensitive C. albicans dominated infections, with other Candida
species rarely observed. Actually C. glabrata is the second most-
commonly isolated Candida species in the European Union and
United States and has high rates of antifungal resistance (Slavin
et al., 2015). Inappropriate antifungal use has contributed to the
increase in antifungal resistance, causing objective complications
for the treatment of invasive fungal infections that nowadays
represent a severe cause of morbidity and mortality among
immunocompromised individuals, neonates and elderly (Brown
et al., 2012). Recent studies indicated that fungal infections may
originate from individual’s own commensal strains suggesting
that the ability of a commensal microorganism to promote
disease is not merely a consequence of impaired host immunity
(Odds et al., 2006), suggesting that rural and other commercial
uses of azole could be the culprit for the emergence of these
resistant strains (Snelders et al., 2012). This underlines the risk
that the increase of antifungal usage outside of the clinic could
also lead to increased resistance to antifungals of individual’s own
commensal strains representing an important epidemiological
problem in the future and remarking the importance to increase
the investment in antifungal research.
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TABLE 3 | Antifungal activity against the most abundant fungal species.
#Species (Number of tested) Antifungal MIC (µg/ml) *CBPs
MIC50 MIC90 %S %SDD %R
Candida albicans (123) Fluconazole 0.5 >64 65.6 0.8 33.4
Itraconazole 2 >8 29.3 5.7 65
5-Flucytosine 0.125 0.5 98.4 0.8 0.8
Candida lusitaniae (6) Fluconazole 0.125 0.5 100 0 0
Itraconazole 0.0156 0.125 100 0 0
5-Flucytosine 0.125 0.125 100 0 0
Candida parapsilosis (40) Fluconazole 0.5 2 92.5 0 7.5
Itraconazole 0.031 >8 75 5 20
5-Flucytosine 0.125 0.125 100 0 0
Penicillium brevicompactum* (13) Fluconazole 0.125 0.125 100 0 0
Itraconazole 0.0156 0.0156 92.5 0 7.5
5-Flucytosine 0.125 0.125 100 0 0
Pichia fermentans* (15) Fluconazole 32 >64 15.4 0 84.6
Itraconazole 0.25 4 44.7 20 33.3
5-Flucytosine 0.5 2 92.3 7.7 0
Pichia kluyveri* (9) Fluconazole 32 32 11.1 0 88.9
Itraconazole 0.125 0.125 88.9 11.1 0
5-Flucytosine 0.5 0.5 100 0 0
Pichia manshurica* (9) Fluconazole 0.25 >64 77.8 0 22.2
Itraconazole 0.0156 >8 77.8 0 22.2
5-Flucytosine 0.125 8 77.8 11.1 11.1
Rhodotorula mucilaginosa* (41) Fluconazole 0.5 >64 63.4 0 36.6
Itraconazole 0.0156 2 75.6 2.4 22
5-Flucytosine 0.125 0.125 100 0 0
Torulaspora delbrueckii* (23) Fluconazole 0.125 8 87 0 13
Itraconazole 0.0156 2 69.6 4.3 26.1
5-Flucytosine 0.125 0.125 100 0 0
*species-specific CBPs are available only for Candida and Aspergillus spp.; for those non-Candida and non-Asperigillus isolates Candida and Asperigillus’ CBPs have been used as a
proxy; #MIC50, MIC90, and CBPs have been calculated only for those species with number of isolates >5; S, sensible; SDD, Sensibility Dose-Dependent or Intermediate; R, resistant.
MIC ranges: Fluconazole 0.125–64µg/ml; Itraconazole 0.0156–8µg/ml; 5-Flucytosine 0.125–64µg/ml.
It should be noted that all the samples analyzed by
metagenomics resulted in high quality fungal sequences,
indicating that all the fecal samples studied had fungal DNA.
So far, the estimated ratio fungi/bacteria of 1:10000 (Huffnagle
and Noverr, 2013), discourages an approach based on whole
metagenome shotgun sequencing (Underhill and Iliev, 2014).
We thus performed amplicon-based ITS1 metagenomics on a
subset of healthy donors identifying more than 90 different
fungal taxa. The first striking evidence was that metagenomics
detected also sequences belonging to Agaricomycetes, among
which several edible fungi, thus suggesting that dietary fungal
intake is a potential confounding effect when studying the
gut mycobiota. On the contrary 34 different fungal species
were isolated using the culture-based approach. Both methods
detected in any case differences in the diverse groups of
study (Supplementary Figure S1). The discrepancies observed
between culture-dependent and culture-independent approaches
on the description of fungal populations could be attributed to
the methodological differences of the two procedures applied
suggesting that several of the fungal taxa identified by the
metagenomics approach are not cultivable, either because we
lack the proper culture conditions or because these belong to
DNA from dead cells, environmental or food-borne fungi that
cannot survive the passage through the GI tract, but whose
DNA is still detectable. Furthermore, the DNA extractionmethod
used in this study could not be suited to extract all the fungal
DNA from the stool samples since the rare taxa Yarrowia,
Starmerella, Rhodosporidium, and Pleurostomophora have been
found only by the culture-based approach. On the other hand
the culture condition that we used might be responsible for some
of the discrepancies observed between the two methods. In our
experience most of the commensal fungi commonly found in the
human gut can be cultivated in YPD, yet other fungi that we were
not able to cultivate might need different culture conditions from
those we used in this work.
Although, for example, S. cerevisiae is often found in
fermented food, it has been shown that it can survive GI tract
challenges being a commensal of the human GI tract (Rizzetto
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et al., 2014) educating also adaptive immunity (Rizzetto et al.,
2016). S. cerevisiae has been introduced in the human intestine
through diet and fermented beverages and it has accompanied
human evolution for at least the past 5150 years (Cavalieri et al.,
2003). Our evidence, together with previous results, including
a recent description of S. cerevisiae in IBDs (Sokol et al., 2016)
showed that this microorganism is a potential commensal of
the human intestine. The overall reduction of the amount and
diversity of fungi introduced through consumption of fermented
beverages suggests that the human gut mycobiota could be
in dynamic change and certain potentially beneficial species
could be lost as a result of modern food processing procedures,
cultural changes, and food globalization. Ongoing studies
on microbial anthropology in human populations consuming
traditional fermented foods, hold the promise to shed light
on the evolution of the fungal microbiota as associated to the
evolution of diet. On the contrary the edible fungi belonging
to Agaricomycetes cannot settle in the human gut due to their
ecology (Hibbett, 2006) so we filtered-out these sequences for
downstream analyses to reduce statistical noises on ecological
measures, improving our results on the characterization of
intestinal fungal communities. We are aware that other taxa
identified by our analyses having environmental and food-borne
origin may not be able to settle in the human gut, however little
is known about these taxa while the Agaricomycetes sequences
that we retrieved had a very low prevalence in the dataset
and mostly belonged to edible fungi such as Boletus, Suillus or
Agrocybe.
We further observed that amplicon-based ITS1metagenomics
cannot confidently describe fungal populations at a deeper
level than genus overlooking species level information provided
by the fungal cultivation approach (see Figures 1B, 2A). On
the other hand, metagenomics analysis detected community
structure differences that fungal cultivation did not identified
(see Figures 2B–D). Nevertheless, the analysis of alpha-diversity
from cultivation data on the subset of subjects used for the
metagenomics analysis revealed no significant differences among
genders remarking that the different sample sizes used in this
work are an additional factor in the discrepancies observed
between the two methods. Although the major limitation of
culture-based methods for the study of microbial communities is
the loss of ecological information due to the inability to cultivate
most microorganisms by standard culturing techniques, fungi
included, culture-based analysis of the human gut mycobiota
is fundamental to discern fungal phenotypes that would be
otherwise lost by metagenomics.
However, population level analyses with both approaches
revealed interesting cues. As occurs for the bacterial microbiota,
the intestinal mycobiota is shaped by host’s age, gender, diet, and
geographical environment (Yatsunenko et al., 2012; Hoffmann
et al., 2013; David et al., 2014). Previous studies have shown
that the development of the gut bacterial microbiota starts at
birth with colonization by a low number of species from the
vaginal and fecal microbiota of the mother and is characterized
by many shifts in composition during infancy (Yatsunenko et al.,
2012). Similarly, the mycobiota may show the same fate, but
we observed an inverted trend in which the richness of the gut
mycobiota of infants (0–2 years old) and children (3–10 years
old) was higher than adults (≥18 years old). It has been shown
that suppression of the bacterial microbiota upon treatment
with antibiotics results in the outgrowth of the gut mycobiota
(Dollive et al., 2013) probably as a consequence of reduced
ecological competition. Similarly, a weak bacterial competition,
in particular during infancy when the bacterial microbiota is
less stable (Koenig et al., 2011; Lozupone et al., 2012), could be
the reason why we observed an increased fungal alpha-diversity
during the early stages of life or this could be due to the different
interactions between intestinal fungi and diet (Hoffmann et al.,
2013; David et al., 2014) which is peculiar during infancy.We also
found that female subjects had a higher number of fungal isolates
and different fungal species compared to male subjects and that
female mycobiota cluster apart from male mycobiota. This may
be ascribed to the role of sex hormones in modulating microbiota
composition (Markle et al., 2013) and of diet in shifting the
microbiota composition in a gender-dependent manner (Bolnick
et al., 2014). Furthermore, the higher relative abundance of
Candida in the fecal samples from female than male subjects
could be also attributed to the prevalence of Candida species in
the vaginal mycobiota (Drell et al., 2013) due to the anatomical
proximity of the two districts. To the best of our knowledge, this
is the first time that gender-related differences are described in
the human gut mycobiota.
In conclusion we can state that culture-independent
approaches are very promising for future investigation of the
mycobiota, but yet require significant improvements in the
selection of markers for amplicon-based metagenomics and
the reference databases. Additionally development of markers
targeting pathogenicity traits, including the genes involved
in host invasion or evasion of immune defenses, or markers
detecting resistance to azoles or other antifungals, is required
to thoughtfully apply metagenomics to fungal infections,
discriminating the healthy mycobiota from an altered one.
Such improvement can be achieved only through systematic
sequencing efforts of the cultivable mycobiota, paralleling what
happened for the prokaryotic microbiota. In our experience,
currently, the combination of the two methods compensated the
methodological limits intrinsic in both approaches avoiding to
overlook significant differences present in the gut mycobiota of
healthy subjects.
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